Copper induces cell death by targeting lipoylated TCA cycle proteins
By P. Tsvetkov, S. Coy, B. Petrova, Margaret B. Dreishpoon, A. Verma, M. Abdusamad, J. Rossen, Lena M Joesch-Cohen, Ranad Humeidi, R. Spangler and 8 more. Science, 2022
3,928 citations recorded by the source corpus.
Copper is an essential cofactor for all organisms, and yet it becomes toxic if concentrations exceed a threshold maintained by evolutionarily conserved homeostatic mechanisms. How excess copper induces cell death, however, is unknown. Here, we show in human cells that copper-dependent, regulated cell death is distinct from known death mechanisms and is dependent on mitochondrial respiration. We show that copper-dependent death occurs by means of direct binding of copper to lipoylated components of the tricarboxylic acid (TCA) cycle. This results in lipoylated protein aggregation and subsequent iron-sulfur cluster protein loss, which leads to proteotoxic stress and ultimately cell death. These findings may explain the need for ancient copper homeostatic mechanisms. Description Copper induces cell death Cell death is an essential, finely tuned process that is critical for the removal of damaged and superfluous cells. Multiple forms of programmed and nonprogrammed cell death have been identified, including apoptosis, ferroptosis, and necroptosis. Tsvetkov et al. investigated whether abnormal copper ion elevations may sensitize cells toward a previously unidentified death pathway (see the Perspective by Kahlson and Dixon). By performing CRISPR/Cas9 screens, several genes were identified that could protect against copper-induced cell killing. Using genetically modified cells and a mouse model of a copper overload disorder, the researchers report that excess copper promotes the aggregation of lipoylated proteins and links mitochondrial metabolism to copper-dependent death. —PNK Lipoylation determines sensitivity to copper-induced cell death.
Subfields: Molecular Biology, Nutrition and Dietetics, Physiology
View Paper: https://www.semanticscholar.org/paper/eedd7fc716cdeb3553f210473938b81ef5e55d73
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Nutrition and Dietetics
In Physiology
- D. Tang
- D. Klionsky
- N. Mizushima
- Katherine R Parzych
- Guido Kroemer
- Beth Levine
- Alec C. Kimmelman
- Yongqiang Chen
Citations in the corpus
- Cuproptosis: mechanisms and links with cancers (2023, background): “Until early this year, it has been suggested by a recent study that cuproptosis is an independent form of cell death, which was considered to be highly correlated with mitochondrial respiration and lipoic acid(LA) pathway [4].”
- Copper homeostasis and cuproptosis in health and disease (2022, background): “Interestingly, metabolite profiling of cells treated with Cu ionophore presents a time-dependent increase in the dysregulation of many TCA cycleassociated metabolites, and inhibiting the electron transport chain complexes I and II significantly reduced Cu-induced cell death.(2) Furthermore, Cu treat”
- Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research (2022, background): “Notably, the cell death pathway induced by Cu ionophores was not prevented by treatment with inhibitors of other already known cell death pathways, such as pan-caspase inhibitors (antiapoptotic compounds), ferrostatin-1 (an antiferroptotic compound), necrostatin-1 (an antinecroptotic compound), or N”
- Copper metabolism in cell death and autophagy (2023, background): “At the molecular level, FDX1 (ferredoxin 1) is a direct target of elesclomol and is required for elesclomol-induced cuproptosis [159,163].”